Somatic drug profiles in patients diagnosed with Major depression: a Danish nationwide register study using Latent Class Analysis
Research output: Contribution to conference › Poster › Communication
Standard
Somatic drug profiles in patients diagnosed with Major depression: a Danish nationwide register study using Latent Class Analysis. / Nielsen, Anne Marije Christina Overgaard ; Jeberg, Pernille Herold ; Wium-Andersen, Marie Kim; Osler, Merete; Jacobsen, Ramune; Almarsdóttir, Anna Birna; Jensen, Kristoffer Jarlov ; Janne, Petersen.
2023. Poster session presented at 10th Nordic Social Pharmacy Conference,Tromsø, Norway.Research output: Contribution to conference › Poster › Communication
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - CONF
T1 - Somatic drug profiles in patients diagnosed with Major depression: a Danish nationwide register study using Latent Class Analysis
AU - Nielsen, Anne Marije Christina Overgaard
AU - Jeberg, Pernille Herold
AU - Wium-Andersen, Marie Kim
AU - Osler, Merete
AU - Jacobsen, Ramune
AU - Almarsdóttir, Anna Birna
AU - Jensen, Kristoffer Jarlov
AU - Janne, Petersen
PY - 2023
Y1 - 2023
N2 - Background and Objectives. Major Depressive Disorder (MDD) is a global health concern and one of the most common comorbidities among patients with somatic diseases. Mapping of prescription drugs for somatic diseases could differentiate MDD patients in terms of somatic burden. This study aimed to identify and characterize the somatic drug profiles among MDD patients at diagnosis and over time.Methods. A nationwide register-based study including all Danish patients with an incident MDD diagnosis between 2011 and 2015 was performed. Latent Class Analysis (LCA) was used to sub-group the population according to somatic drug use (drug profiles). The changes between somatic drug profiles were depicted in four different time intervals from 3 years prior MDD diagnosis to 3 years after the MDD diagnosis.Results. The study population comprised 37,080 MDD patients (mean age 41.5 years, 62% women). The LCA identified five somatic drug profiles: 1) limited drug use (74.3%), 2) drugs for pain management (7.6%), 3) cardiovascular drugs (10.7%), 4) drugs for obstructive airway diseases (2.3%), 5) high drug burden (5.1%). The limited drug use profile included 96% of the population younger than 35, the other drug profiles mainly included patients older than 35. The majority of the population continued in the same drug profile during all time intervals. Movement between drug profiles over time was most common in the population older than 35. Conclusions. Using data driven methods on prescription drugs for treatment of somatic diseases, five somatic drug profiles, generally stable over time, were identified in patients with MDD.
AB - Background and Objectives. Major Depressive Disorder (MDD) is a global health concern and one of the most common comorbidities among patients with somatic diseases. Mapping of prescription drugs for somatic diseases could differentiate MDD patients in terms of somatic burden. This study aimed to identify and characterize the somatic drug profiles among MDD patients at diagnosis and over time.Methods. A nationwide register-based study including all Danish patients with an incident MDD diagnosis between 2011 and 2015 was performed. Latent Class Analysis (LCA) was used to sub-group the population according to somatic drug use (drug profiles). The changes between somatic drug profiles were depicted in four different time intervals from 3 years prior MDD diagnosis to 3 years after the MDD diagnosis.Results. The study population comprised 37,080 MDD patients (mean age 41.5 years, 62% women). The LCA identified five somatic drug profiles: 1) limited drug use (74.3%), 2) drugs for pain management (7.6%), 3) cardiovascular drugs (10.7%), 4) drugs for obstructive airway diseases (2.3%), 5) high drug burden (5.1%). The limited drug use profile included 96% of the population younger than 35, the other drug profiles mainly included patients older than 35. The majority of the population continued in the same drug profile during all time intervals. Movement between drug profiles over time was most common in the population older than 35. Conclusions. Using data driven methods on prescription drugs for treatment of somatic diseases, five somatic drug profiles, generally stable over time, were identified in patients with MDD.
M3 - Poster
T2 - 10th Nordic Social Pharmacy Conference,Tromsø, Norway
Y2 - 7 June 2023 through 9 June 2023
ER -
ID: 355259744